These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 16939037

  • 1. To box OR NOT TO box.
    Newstadt M.
    J Ky Med Assoc; 2006 Aug; 104(8):344-5. PubMed ID: 16939037
    [No Abstract] [Full Text] [Related]

  • 2. ADHD drugs and cardiovascular risk.
    Rappley MD, Moore JW, Dokken D.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract] [Full Text] [Related]

  • 3. ADHD drugs and cardiovascular risk.
    Nissen SE.
    N Engl J Med; 2006 Apr 06; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. ADHD drugs and cardiovascular risk.
    Anders T, Sharfstein S.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16723628
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ADHD black box warning: how concerned should we be?
    Cruz R, Kutscher EC.
    S D Med; 2007 Feb 25; 60(2):63, 65. PubMed ID: 17390569
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN.
    J Contemp Health Law Policy; 2003 Feb 25; 19(2):495-520. PubMed ID: 14748255
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL, American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee, American Heart Association Council on Cardiovascular Nursing.
    Circulation; 2008 May 06; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM, Friedman RA, Knilans TK, Black Box Working Group, Section on Cardiology and Cardiac Surgery.
    Pediatrics; 2008 Aug 06; 122(2):451-3. PubMed ID: 18676566
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B, Towbin K.
    Am J Psychiatry; 2009 Sep 06; 166(9):955-7. PubMed ID: 19528196
    [No Abstract] [Full Text] [Related]

  • 20. Stimulants for kids with ADHD--how to proceed safely.
    Ken Mehta S, Jacobs I.
    J Fam Pract; 2014 Feb 06; 63(2):E1-5. PubMed ID: 24527478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.